Evaluation of thermal and non-thermal processing effect on non-prebiotic and prebiotic acerola juices using 1HqNMR and GC - MS coupled to chemometrics.

Made available in DSpace on 2018-06-07T01:06:53Z (GMT). No. of bitstreams: 1 ART18020.pdf: 999884 bytes, checksum: c3f3c746d6d1f87960b32b066460fd07 (MD5) Previous issue date: 2018-06-04bitstream/item/178272/1/ART18020.pd

Algumas propriedades farmacológicas de extratos de plantas do nordeste brasileiro

Extratos hidroalcoólicos de plantas do Nordeste brasileiro foram testados nas preparações reto abdominal de sapo, duodeno isolado de coelho, coração isolado de anfíbio e útero isolado de rata. As seguintes plantas foram consideradas inativas: Marmeleirinho (Croton sp-33), Azeitona (Eugenia jambolana), Pimenta de macaco (Piper sp-06), Imburana de espinho (Bursera leptophilococos), Espirro (Siperuna guianensis), Araticum (Annona careacea) e Hyptis sp. No tocante aos que se apresentam ativos destacam-se Jurema (Mimosa acutistipula), canafístula de boi (Pithecolobium multiflorum) Castanha de burro (Dipterix alata), Goiabeira (Psidium guajava), Flamboyan (Delonix regia) e Capim cidreira (Cymbopogon citratus)

METHYLPHENIDATE: PROCONVULSANT EFFECT AND ACTION ON ACETYL CHOLINESTERASE ACTIVITY IN YOUNG AND ADULT MICE

Objective: Methylphenidate (MPH) is a derivative of piperidine, structurally related to amphetamine. It is the most widely psychostimulant used in Brazil for treating attention deficit disorder and hyperactivity. This drug was investigated in an epilepsy model induced by pilocarpine and on acetylcholinesterase (AChE) activity in young and adult mice. Methods: The control group was treated with saline. The treated groups received MPH (2.5, 5, 10 or 20 mg/kg) in single dose, followed by pilocarpine (400mg/Kg). The groups were observed for1h after treatment. Results: MPH, in all doses, was efficacious in decreasing both the latency to first seizures and the survival percentage in young and adult animals. Determination of AChE activity in the hippocampus and striatum of young and adult animals, after pilocarpine-induced status epilepticus, demonstrated that pretreatment with MPH reduced AChE activity only in the striatum. Conclusion: Our findings suggest that MPH has proconvulsant action and cholinergic neurotransmission system can play a role in this effect

Determinant Factors of Dividend Payments in Brazil

This study identifies factors that shaped cash disbursement distribution policies employed by Brazilian public companies listed on the Brazilian Securities, Commodities and Futures Exchange (BM&FBOVESPA) from 1995 to 2011. Relationships between Dividends/Total Assets and potential determinants discussed in the literature, including firm size, corporate governance, profitability, leverage, market to book, liquidity, investment, risk, profit growth, information asymmetry and agency conflict, are examined. The following econometric methods are employed: (1) Tobit, given the nature of the dividend data, and (2) the Generalized Method of Moments (GMM) to control for endogenous regressors. Significant positive variables found include size, return on assets (ROA), market to book, liquidity and profit growth. It can thus be inferred that larger firm size, profitability, market value, liquidity and profit growth correlate with greater firm pro pensity to distribute money to shareholders, thus supporting the theory of corporate finance. Significant negative variables found include leverage, liquidity squared, capex, beta and tag along 100%. It is thus inferred that more significantly leveraged companies that invest more heavily in fixed assets and that exhibit high liquidity, higher risk and less conflict between controlling and minority shareholders will be less likely to pay dividends to shareholders.</p

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase&nbsp;1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation&nbsp;disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age&nbsp; 6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score&nbsp; 652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc&nbsp;= 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N&nbsp;= 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in&nbsp;Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in&nbsp;Asia&nbsp;and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Algumas propriedades farmacol\uf3gicas de hidrolatos de plantas do nordeste brasileiro

Um dos aspectos mais interessantes do nosso programa de plantas medicinais foi a descoberta do efeito farmacológico do codestilado da coleta para obtenção de óleos essenciais (hidrolatos). Na presente pesquisa foram testados os efeiros de varios hidrolatos no reto abdominal de sapo, no duodeno de coelho, no útero de rata e em corações de anfíbios. Apresentaram efeitos consideráveis hidrolatos de Endro (Foenculum vulgare) alecrim de tabuleiro (Lippia gracilis) velame (Croton sp.), marmeleiro branco (Croton nepetifolius) e Vandelia sp. Foram destituídas de efeitos nesses ensaios: Laranja (Citrus araticum), Azeitona (Sizygium jambolana), Melosa (Hyptis crenata), Maracujá (Passiflora edulis). Pau d'óleo (Copaifera langsdorfii), limãozinho (Fagara sp.), Bananinha (Dugvetia sp.), Hyptis sp., Samba coité (Hyptis sp. -10), Cravo de defunto (Tagetes minuta), Camarazinho (Lippia sp.-15), Ata brava (Annona sp.-01), Araticum (Annona coreacea) e Tipi (Petiveria alliacea)